Ide, Takafumi
https://orcid.org/0000-0003-4164-4593
Mayo Clinic
Bristol-Myers Squibb (United States)
Citations 2
OC.57 Safety and efficacy of CD19 NEX-T® (BMS-986353), a chimeric antigen receptor (CAR) T cell therapy, in systemic sclerosis (SSc): findings from the breakfree-1 trial
Khanna, D, Korman, David S., Mease, Philip, Griffith, Melissa, Carpintero, Maria , Wener, Mark H. , Kramer, Neil , Schett, G, Mayes, Maureen D., Melton, Alexis, Handy, Whitney, Ou, San-San, Jarugula, Praneeth , Ide, Takafumi , Harnois, Melissa, Thorpe, Jerill , Koegel, Ashley, Wiesendanger, Margrit, Harnois, Melissa J. , Khanna, Dinesh , Majithia, Vikas , Bernstein, Elana J. , Mease, Philip J. , Simon, David , Schett, Georg , Gómez‐García, Ignacio , Mayes, Maureen D. , Desai, Alisha, Handy, Whitney, Ou, San‐San , Ide, Takafumi, Koegel, Ashley K., Wiesendanger, Margrit
Oral Communications | June 5, 2026 | Volume: No volume available | Issue: No issue available | Pages: A61-A63
S15:01 Safety and efficacy of CD19 NEX-T® (BMS-986353)—a CD19-directed chimeric antigen receptor (CAR) T cell therapy—for severe refractory systemic lupus erythematosus (SLE): breakfree-1 trial update
Simon, David Nils , Wiesendanger, Margrit, Langhe, Ellen De, Askanase, A., Schett, Georg, Saxena, Amit, Kramer, Neil E., Mease, P, Schmalzing, Marc , Melton, Alexis, Law, Brandon M., Handy, Whitney, McTume, Griff, Ide, Takafumi , Harnois, Melissa J. , Thorpe, Jerill , Koegel, Ashley Kern, Littlejohn, Emily , Simon, David , Langhe, Ellen De , Majithia, Vikas , Schett, Georg , Saxena, Amit , Kramer, Neil, Desai, Alisha, McTume, G., Ide, Takafumi
Oral Presentations | March 2, 2026 | Volume: No volume available | Issue: No issue available | Pages: A24-A25